Working… Menu

Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients (APV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02275702
Recruitment Status : Unknown
Verified March 2016 by Laval University.
Recruitment status was:  Recruiting
First Posted : October 27, 2014
Last Update Posted : March 9, 2016
Information provided by (Responsible Party):
Laval University

Brief Summary:
The proposed study is a randomized, double-blind, placebo-controlled evaluation if a small dose of IV dexamethasone during induction anesthesia in association to pre and postoperative intercostal nerve block, improves quality of recovery of thoracoscopic lung resection patients.

Condition or disease Intervention/treatment Phase
- Lung Cancer Drug: Dexamethasone IV Drug: Saline solution Phase 4

Detailed Description:

This is a study composed by 2 groups of 50 patients undergoing VATS for lung cancer. All subjets will receive intraoperative intercostal nerve block with a maximum dose of 2 mg/kg of bupivacaine with epinephrine 1:200.000 at the beginning and at the end of procedure.

The control group will receive a bolus dose of dexamethasone (0.1 mg/kg) and the placebo group saline solution. The study drug or placebo will be administered at the time of anesthetic induction (approximately 30 minutes before surgical incision). Patients will be evaluated daily with the quality of recovery questionary, visual analogue pain and portable spirometry. And, the patients will have pulmonary lung function assessed by portable spirometry.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Official Title: Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients
Study Start Date : October 2014
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Placebo Comparator: Group 1
saline solution IV, bolus
Drug: Saline solution
Active Comparator: Group 2
0,1mg/kg systemic dose of dexamethasone, bolus
Drug: Dexamethasone IV
It will be administered at the induction of the anesthesia
Other Name: Decadron

Primary Outcome Measures :
  1. The primary outcome of this study will be postoperative quality of recovery measured by postoperative quality of recovery score 40 (QoR-40) global score. [ Time Frame: During the hospital stay and 1 year later ]

Secondary Outcome Measures :
  1. Time of analgesia between the final intercostal nerve block and the first patient-controlled analgesia (PCA) request; [ Time Frame: During the hospital stay and 1 year later ]

Other Outcome Measures:
  1. Correlation between pain with visual analog scale and lung function through spirometry test with forced expiratory volume at one second (FEV1) and diffusion capacity (DLCO) [ Time Frame: During the hospital stay and 1 year later ]
  2. Total opioid dose consumption in each group [ Time Frame: During the hospital stay and 1 year later ]
  3. Side-effect of dexamethasone in the stress response to surgery [ Time Frame: During the hospital stay and 1 year later ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • resectable stage I and II lung cancer patients submitted to VATS
  • american society of anesthesiology Classification (ASA) I or II

Exclusion Criteria:

  • chronic pain;
  • chronic analgesic consumption;
  • severe renal or liver disease;
  • endocrine or mental diseases;
  • poorly controlled diabetes;
  • allergy to bupivacaine;
  • previous thoracotomy;
  • systemic use of corticosteroids;
  • morbid obesity;
  • poor French comprehension precluding completion of the QoR-40 questionnaire;
  • patient refusal.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02275702

Layout table for location contacts
Contact: Guilherme Dal Agnol, Fellowship +14185707295

Layout table for location information
Canada, Quebec
Institut Universitaire de Cardiologie et de Pneumologie de Québec, IUCPQ Not yet recruiting
Québec, Quebec, Canada, G1v 4G5
Contact: Guilherme Dal Agnol, Fellowship    +14185707295   
Principal Investigator: Paula A Ugalde, Medicin         
Sub-Investigator: Jean Bussières, Medicin         
Sub-Investigator: Yves Lacasse, Medicin         
Sub-Investigator: Guilherme Dal Agnol, Medicin         
Sub-Investigator: Nathalie Gagné, Nurse         
IUCPQ Recruiting
Québec, Quebec, Canada, G1V3H8
Contact: Guilherme Dal Agnol, fellow    4185707295   
Sponsors and Collaborators
Laval University
Layout table for investigator information
Principal Investigator: Paula A. Ugalde, Medicin Institut Universitaire de Cardilogie et Pneumologie de Québec, IUCPQ

Layout table for additonal information
Responsible Party: Laval University Identifier: NCT02275702     History of Changes
Other Study ID Numbers: APV-100
First Posted: October 27, 2014    Key Record Dates
Last Update Posted: March 9, 2016
Last Verified: March 2016
Keywords provided by Laval University:
Quality of recovery questionnaire
Lung cancer
Video-assisted thoracoscopic
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Dexamethasone acetate
BB 1101
Anti-Inflammatory Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Protease Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action